Supplementation with nicotinamide riboside may improve muscle mitochondrial biogenesis, according to data from a first-of-its kind five-month-long clinical study with twins.
America’s nicotinamide riboside (NR) maker Chromadex is eyeing omnichannel retail in China and is confident of achieving the ‘blue-hat’ health foods registration status – required for normal trade of health foods in China – in the next 24 months or less....
Branded ingredient supplier ChromaDex announced an 18% sales gain in a recent earrings report. A continued push to increase the science behind its TruNiagen brand is part of the reason, the company’s co-founder said.
As the ChromaDex External Research Program passes a significant milestone with 250 material transfer agreements (MTAs), are there lessons for the rest of the industry to learn about building out R&D programs?
Supplement manufacturer ChromaDex alleges that testing has revealed that more than half of NMN anti aging supplements being sold on Amazon contained almost none of the bioactive molecule.
With recent data providing “solid evidence” for nicotinamide riboside’s effects on inflammation and body composition, combining NR with exercise will see us “really get some place”, says Dr Charles Brenner.
A new study shows ChromaDex’s Tru Niagen ingredient can alleviate hearing loss in a mouse mode of a rare genetic condition. The data broadens the anti aging potential of the company’s flagship product.
California-based ChromaDex announced that Nestlé Health Science now has “exclusive right” to include ChromaDex’s patented nicotinamide riboside ingredient Tru Niagen in its branded medical nutrition products.
